Not Yet RecruitingNot Applicable

Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trials

10 participantsStarted 2026-04-21

Plain-language summary

The intellidrop device is an FDA-approved system that automates safe, small volume of cerebral spinal fluid drainage with continuous pressure monitoring, reducing nursing workload and human error while improving patient mobility and comfort

Who can participate

Age range60 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients will be adults aged 60 years or older with suspected iNPH who are being admitted to the hospital for the purpose of an LDT specifically to evaluate for benefit from shunt placement. Exclusion Criteria: * Patients who are under 18 years of age, pregnant, or are currently incarcerated will be excluded from participating in this study.

What they're measuring

Feasibility

Timeframe: FIM scores will be obtained on a daily basis during month 3 - 5.

Acceptability

Timeframe: from enrollment to the end of three months or until 10 subjects have been enrolled

Trial details

NCT IDNCT07494812

SponsorUniversity of Texas Southwestern Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-31

Contact for this trial

Padraig O'Suilleabhain, M.D.

214-648-2943 padraig.osuilleabhain@utsouthwestern.edu

View on ClinicalTrials.gov More NPH (Normal Pressure Hydrocephalus) trials